p-medicine
From data sharing and integration via VPH models to personalised medicine
| Coordinatore | UNIVERSITAET DES SAARLANDES
Organization address
address: 9 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 17˙888˙031 € |
| EC contributo | 13˙329˙898 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2009-6 |
| Funding Scheme | CP |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-02-01 - 2015-01-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITAET DES SAARLANDES
Organization address
address: 9 contact info |
DE (SAARBRUECKEN) | coordinator | 0.00 |
| 2 |
A. PERSIDIS & SIA OE
Organization address
address: RODOPOLEOS STREET 34 contact info |
EL (ATHINA) | participant | 0.00 |
| 3 |
CUSTODIX NV
Organization address
address: KORTRIJKSESTEENWEG 214 b3 contact info |
BE (SINT-MARTENS-LATEM) | participant | 0.00 |
| 4 |
ecancermedicalscience AG
Organization address
address: c/o Bruno Wanner Management, Gotthardstrasse 20 contact info |
CH (Zug) | participant | 0.00 |
| 5 |
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH
Organization address
address: STUHSATZENHAUSWEG 69 contact info |
DE (SAARBRUCKEN) | participant | 0.00 |
| 6 |
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
Organization address
address: N PLASTIRA STR 100 contact info |
EL (HERAKLION) | participant | 0.00 |
| 7 |
FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V
Organization address
address: HANSASTRASSE 27C contact info |
DE (MUNCHEN) | participant | 0.00 |
| 8 |
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER
Organization address
address: Welfengarten 1 contact info |
DE (HANNOVER) | participant | 0.00 |
| 9 |
HEINRICH-HEINE-UNIVERSITAET DUESSELDORF
Organization address
address: UNIVERSITAETSSTRASSE 1 contact info |
DE (DUSSELDORF) | participant | 0.00 |
| 10 |
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
Organization address
address: Patission Str. 42 contact info |
EL (ATHINA) | participant | 0.00 |
| 11 |
INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK
Organization address
address: NOSKOWSKIEGO 12-14 contact info |
PL (POZNAN) | participant | 0.00 |
| 12 |
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Organization address
address: Via Filodrammatici 10 contact info |
IT (MILANO) | participant | 0.00 |
| 13 |
KOKURITSU DAIGAKU HOJIN HOKKAIDO DAIGAKU
Organization address
address: KITA 8 NISHI 5 KITA KU contact info |
JP (SAPPORO) | participant | 0.00 |
| 14 |
MEDIZINISCHE HOCHSCHULE HANNOVER
Organization address
address: Carl-Neuberg-Strasse 1 contact info |
DE (HANNOVER) | participant | 0.00 |
| 15 |
PHILIPS ELECTRONICS NEDERLAND B.V.
Organization address
address: Boschdijk 525 contact info |
NL (EINDHOVEN) | participant | 0.00 |
| 16 |
SWISS INSTITUTE OF BIOINFORMATICS
Organization address
address: Rue Michel Servet 1 contact info |
CH (GENEVE) | participant | 0.00 |
| 17 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 0.00 |
| 18 |
UNIVERSIDAD POLITECNICA DE MADRID
Organization address
address: CALLE RAMIRO DE MAEZTU 7 EDIFICIO RECTORADO contact info |
ES (MADRID) | participant | 0.00 |
| 19 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Medicine is undergoing a revolution that is transforming the nature of healthcare from reactive to preventive. The changes are catalyzed by a new systems approach to disease which focuses on integrated diagnosis, treatment and prevention of disease in individuals. This will replace our current mode of medicine over the coming years with a personalized predictive treatment . While the goal is clear, the path is fraught with challenges.P-medicine brings together international leaders in their fields to create an infrastructure that will facilitate this translation from current practice to personalized medicine. In achieving this objective p-medicine has formulated a coherent, integrated workplan for the design, development, integration and validation of technologically challenging areas of today.Our emphasis is on formulating an open, modular framework of tools and services, so that p-medicine can be adopted gradually, including efficient secure sharing and handling of large personalized data sets, enabling demanding Virtual Physiological Human (VPH) multiscale simulations (in silico oncology), building standards-compliant tools and models for VPH research, drawing on the VPH Toolkit and providing tools for large-scale, privacy-preserving data and literature mining, a key component of VPH research. We will ensure that privacy, non-discrimination, and access policies are aligned to maximize protection of and benefit to patients. The p-medicine tools and technologies will be validated within the concrete setting of advanced clinical research. Pilot cancer trials have been selected based on clear research objectives, emphasising the need to integrate multilevel datasets, in the domains of Wilms tumour, breast cancer and leukaemia. To sustain a self-supporting infrastructure realistic use cases will be built that will demonstrate tangible results for clinicians.The project is clinically driven and promotes the principle of open source and open standards.